Baxter agrees to sell cell vaccine business

SHARE Baxter agrees to sell cell vaccine business

Baxter International Inc. has agreed to sell a cell-based technology for making vaccines to Nanotherapeutics Inc. Terms weren’t disclosed.

The Deerfield-based drugmaker is selling its Vero cell technology and related operations, including a production plant in Czech Republic. The cell technology is used in making flu vaccines as well as investigational vaccines for West Nile virus and others.

“The divestiture of the vaccines franchise will allow Baxter BioScience to enhance focus in core therapeutic areas of hematology, oncology and immunology, as it prepares to become an independent biopharmaceutical company,” said Ludwig Hantson, president of Baxter BioScience.

The Latest
Despite getting into foul trouble, which limited him to just six minutes in the second half, Shannon finished with 29 points, five rebounds and two assists.
Cowboy hats, bell-bottoms and boots were on full display Thursday night as fans lined up for the first of his three sold-out shows.
The incident occurred about 3:40 p.m. near Minooka. The horse was successfully placed back into the trailer, and the highway reopened about 40 minutes later. No injuries were reported.
The Hawks conceded the game’s only two goals within the first seven minutes and were shut out for the 12th time this season in a 2-0 defeat Thursday.